JOURNAL OF CELL SCIENCE, with ISSN 0021-9533 and E-ISSN 1477-9137, is a distinguished publication in the field of Cell Biology, released by COMPANY BIOLOGISTS LTD in the United Kingdom. Since its inception in 1966, this journal has served as a vital platform for disseminating cutting-edge research and reviews that significantly advance our understanding of cellular processes and innovations. Currently positioned in the Q1 category within the 2023 rankings, this journal is recognized for its high impact and quality, holding a notable Scopus rank of 120 out of 285 in the Cell Biology category, placing it within the 58th percentile. While not an open-access journal, it provides extensive access options for readers and institutions, ensuring that pivotal research is accessible to a wide audience. With converged publication years leading toward 2024, JOURNAL OF CELL SCIENCE continues to be an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of the intricate workings of cell biology.

European Biophysics Journal with Biophysics Letters is a leading academic journal published by Springer that focuses on innovative research in the field of biophysics. Founded in 1984, it has consistently provided a platform for the dissemination of high-quality scientific findings, bridging the gap between biophysics and its applications in medicine and related fields. With an ISSN of 0175-7571 and an E-ISSN of 1432-1017, this journal has established itself as a Q2-rated publication in both Biophysics and Miscellaneous Medicine, highlighting its influential role in advancing knowledge and fostering collaboration among researchers. The journal features original research articles, reviews, and technical notes that contribute significantly to our understanding of biological systems at a molecular level. Although it does not offer an open-access model, the journal remains committed to promoting scholarly communication and enhancing the visibility of biophysical research globally. By maintaining a Scopus Rank of #74/152 within the category of Biochemistry, Genetics and Molecular Biology, it positions itself as an essential resource for professionals, researchers, and students aiming to stay at the forefront of biophysical science.

TISSUE & CELL is a prominent academic journal, published by CHURCHILL LIVINGSTONE, that has been at the forefront of research in the fields of cell biology, developmental biology, and miscellaneous areas of medicine since its inception in 1969. With a strong focus on high-quality research, TISSUE & CELL has established itself within the academic community, holding a Q3 ranking in both Cell Biology and Developmental Biology, and a Q2 ranking in Medicine as of 2023. The journal aims to disseminate significant findings that contribute to the understanding of tissue structure and function, helping to bridge the gap between basic biological research and clinical applications. While it operates on a subscription basis and does not currently offer Open Access options, the journal remains a vital resource for researchers, professionals, and students interested in cutting-edge developments in the biological sciences. The journal's address is located in the scenic city of Edinburgh, further establishing its academic heritage in the United Kingdom.

Photobiomodulation Photomedicine and Laser Surgery is a premier peer-reviewed journal published by MARY ANN LIEBERT, INC, dedicated to advancing the understanding of light-based therapies in biomedical applications. With an impressive impact factor, this journal occupies a significant position in the field of Biomedical Engineering and Radiology, Nuclear Medicine and Imaging, evidenced by its placement in the Q3 category for both fields as of 2023. The journal's scope encompasses a wide array of research topics, including but not limited to, the therapeutic effects of photobiomodulation and innovative laser surgical techniques. Researchers and practitioners alike can benefit from its open-access format, facilitating the dissemination of cutting-edge findings to a global audience. By bridging the gap between scientific inquiry and clinical application, Photobiomodulation Photomedicine and Laser Surgery plays a crucial role in fostering the integration of advanced technologies in healthcare, enhancing patient outcomes and pushing the boundaries of medical science.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES is a prestigious journal dedicated to advancing the field of biomembrane research, published by Elsevier. With a notable track record since its inception in 1967, this journal operates under the dual ISSN 0005-2736 and E-ISSN 1879-2642, and has firmly established itself within the scientific community by ranking in the top tiers of various disciplines, including Q2 in Biochemistry and Cell Biology, and Q1 in Biophysics as of 2023. Its impressive Scopus rankings further underscore its importance, with a rank of 24 in Biophysics reflecting its strong impact on ongoing research. Although it does not offer open access, the journal provides comprehensive insights and breakthroughs essential for scientists, researchers, and advanced students focused on biophysical and biochemical aspects of membranes. By disseminating pivotal findings, BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES contributes significantly to understanding cellular mechanisms, thereby serving as a vital resource for professionals aiming to explore the complexities of biological membranes.

Journal of Biological Engineering, published by BMC, stands as a prominent Open Access journal since 2007, dedicated to advancing the interdisciplinary field of biological engineering. With an ISSN of 1754-1611, this UK-based journal aims to provide a platform for researchers and professionals to disseminate innovative and impactful research across various domains including Biomedical Engineering, Environmental Engineering, Cell Biology, and Molecular Biology. The journal's notable rankings in the 2023 category quartiles exemplify its position within the scientific community, featuring Q2 status in Biomedical Engineering and Environmental Engineering, along with Q3 in Cell Biology and Q2 in Molecular Biology. By maintaining robust Scopus rankings and ensuring free access to cutting-edge research, the Journal of Biological Engineering plays a crucial role in driving discovery and collaboration among scholars, thereby enriching both the academic landscape and applied sciences.

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.

The Journal of Tissue Engineering, published by SAGE Publications Inc., stands at the forefront of innovation in the interdisciplinary fields of biomaterials and biomedical engineering. Established as an open access journal since 2010, it has quickly ascended to a leading position, as evidenced by its impressive rankings in 2023: Q1 in Biomaterials, Q1 in Biomedical Engineering, and Q1 in Medicine (miscellaneous). With a current impact factor that underscores its academic influence, this journal provides a vital platform for researchers, professionals, and students to share groundbreaking discoveries and advancements in tissue engineering and regenerative medicine. Located in the United Kingdom, the journal fosters a global dialogue with its robust publications and rigorous peer-review process, contributing significantly to the enhancement and understanding of complex biological systems. Join the esteemed community of thought leaders and innovators shaping the future of healthcare through the Journal of Tissue Engineering.

Frontiers in Cell and Developmental Biology is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of fundamental biological processes at the cellular and developmental levels. Since its inception in 2013, the journal has positioned itself as a cornerstone of research in its field, achieving esteemed Q1 quartile rankings in both Cell Biology and Developmental Biology for 2023. With a robust Scopus ranking of #13 out of 82 in Developmental Biology and #67 out of 285 in Cell Biology, it represents a vital platform for innovative research and scholarly discourse. The journal provides a comprehensive and accessible avenue for researchers, professionals, and students alike to share high-quality findings and insights into cellular mechanisms and developmental processes, fostering collaboration and knowledge exchange in the global scientific community. Based in Lausanne, Switzerland, Frontiers in Cell and Developmental Biology is committed to open science, ensuring that all articles are freely accessible to the public, thereby broadening the impact of research in the biological sciences.

Current Stem Cell Research & Therapy, published by Bentham Science Publishers Ltd, is a leading journal dedicated to advancing the field of stem cell research. With an ISSN of 1574-888X and an E-ISSN of 2212-3946, this journal has been a valuable resource since its inception in 2006 and continues to broaden its scope through 2024. Recognized in the Q2 quartile for Medicine (miscellaneous) and ranked in the 66th percentile among its peers, the journal plays a crucial role in disseminating high-quality, peer-reviewed research that explores both the therapeutic and biological implications of stem cells. Located in the United Arab Emirates, Current Stem Cell Research & Therapy embraces a global audience of researchers, professionals, and students, providing a vibrant platform for discourse and innovation. While the journal offers subscription-based access, it remains committed to enhancing the scientific community's understanding of stem cell therapy and its applications across various medical fields.